Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Microbot Medical Inc. (MBOT)

1.0400 -0.0500 (-4.59%)
At close: November 2 at 4:00:01 PM EST
1.0700 +0.0300 (+2.88%)
Pre-Market: 4:00:15 AM EST
Trade MBOT on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Harel Gadot
Co-Founder, President, CEO & Chairman 1.31M -- 1973
Ms. Rachel Vaknin
Chief Financial Officer 376.08k -- 1979
Dr. Simon Sharon MBA, MSc
CTO & GM of Microbot Israel 523.67k -- 1960
Dr. Juan Diaz-Cartelle
Chief Medical Officer 497.41k -- 1976
Ms. Christina Bailey
Vice President of Sales -- -- --
Ms. Allison Rosefort
Vice President of Marketing -- -- --
Naama Moav
Vice President of Human Resources -- -- --
Mr. Michael Lytle
Head of Sales Operations & Analytics -- -- --

Microbot Medical Inc.

175 Derby Street
Bld. 27
Hingham, MA 02043
United States
781 875 3605 https://microbotmedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
43

Description

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Corporate Governance

Microbot Medical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

October 27, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 23, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 20, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 6, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 28, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 11, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 21, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 30, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: